Plasmodium vivax blood stage antigens

Details Plasmodium vivax blood stage antigens Plasmodium vivax blood stage antigens

1996-09-30

1999-02-23

Duffy, Patricia

Chemistry: natural resins or derivatives; peptides or proteins;

Peptides of 3 to 100 amino acid residues

530350, 5303886, 4241841, 4241851, 4241911, 4242681, A61K 3800, A61K 39015

Patent

active

058745270

ABSTRACT:
This invention is directed to novel species-specific P. vivax malarial peptide antigens which are proteins or fragments of proteins secreted into the plasma of a susceptible mammalian host after infection, and to monoclonal or polyclonal antibodies directed against those antigens. The peptide antigens, monoclonal antibodies, and/or polyclonal antibodies are utilized in assays used to diagnose malaria, as well as to determine whether Plasmodium vivax is the species responsible for the infection.

Affiliated with

Also associated with

Rating

Plasmodium vivax blood stage antigens does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Plasmodium vivax blood stage antigens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Plasmodium vivax blood stage antigens will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-308032